Skip to main content
PMC home page
Clinical and Experimental Immunology logoLink to Clinical and Experimental Immunology
. 1994 Jun;96(3):379–383. doi: 10.1111/j.1365-2249.1994.tb06038.x

Circulating autoantibodies directed against conjugated fatty acids in sera of HIV-1-infected patients.

A Amara 1, C Chaugier 1, J M Ragnaud 1, M Geffard 1
PMCID: PMC1534576  PMID: 7911749

Abstract

Several reports have demonstrated that major changes occur in the fatty acid content of HIV-infected cells. In order to evaluate if these changes are recognized by the immune system, we have attempted to assay the possible presence of autoantibodies (autoAb) directed against conjugated fatty acids (CFA). Using an adapted ELISA, anti-CFA autoAb were assayed in sera of 150 HIV-1-infected patients and 116 controls (healthy donors and patients suffering from other diseases). Significantly increased anti-CFA autoAb of IgG class were found in HIV-1-infected patients (alpha < 0.001). Using our ELISA method and CFA differing in their length and their degree of unsaturation (lauric, myristic, palmitic, palmitoleic, stearic, oleic, linolenic, linoleic, lignoceric, arachidonic, eicosapentaenoic and docosahexaenoic acids), it was demonstrated that the acyl chain of CFA is the immunodominant part recognized by these autoAb. Anti-CFA autoAb were present in 15/52 asymptomatic carriers, 14/36 symptomatic carriers, 16/39 ARC patients, but only 3/23 AIDS patients. Anti-CFA activity seemed to be linked with the CD4+ T cell count, and was not related to the total IgG amounts. Anti-CFA autoAb could result from self-antigen presentation to immunological cells, and may reflect lipid membrane modifications occurring in HIV-infected cells.

Full text

PDF
379

Selected References

These references are in PubMed. This may not be the complete list of references from this article.

  1. Apostolov K., Barker W., Galpin S. A., Habib N. A., Wood C. B., Kinchington D. Syncytia formation in HIV-1 infected cells is associated with an increase in cellular oleic acid. FEBS Lett. 1989 Jul 3;250(2):241–244. doi: 10.1016/0014-5793(89)80730-6. [DOI] [PubMed] [Google Scholar]
  2. Apostolov K., Barker W., Wood C. B., Habib N. A., Jeffries D., Forster S. M. Fatty acid saturation index in peripheral blood cell membranes of AIDS patients. Lancet. 1987 Mar 21;1(8534):695–695. doi: 10.1016/s0140-6736(87)90469-7. [DOI] [PubMed] [Google Scholar]
  3. Calabrese L. H. Autoimmune manifestations of human immunodeficiency virus (HIV) infection. Clin Lab Med. 1988 Jun;8(2):269–279. [PubMed] [Google Scholar]
  4. Callahan L. N., Roderiquez G., Mallinson M., Norcross M. A. Analysis of HIV-induced autoantibodies to cryptic epitopes on human CD4. J Immunol. 1992 Sep 15;149(6):2194–2202. [PubMed] [Google Scholar]
  5. Crise B., Rose J. K. Identification of palmitoylation sites on CD4, the human immunodeficiency virus receptor. J Biol Chem. 1992 Jul 5;267(19):13593–13597. [PubMed] [Google Scholar]
  6. Daverat P., Geffard M., Orgogozo J. M. Identification and characterization of anti-conjugated azelaic acid antibodies in multiple sclerosis. J Neuroimmunol. 1989 Apr;22(2):129–134. doi: 10.1016/0165-5728(89)90043-x. [DOI] [PubMed] [Google Scholar]
  7. Faiderbe S., Chagnaud J. L., Charrier M. C., Peyron M. A., Wafflart J., Geffard M. Autoantibodies directed against lipid membrane components in sera of patients with malignant tumors. Cancer Detect Prev. 1991;15(3):199–203. [PubMed] [Google Scholar]
  8. Kennedy J. R. AIDS--an autoimmune model. Med Hypotheses. 1992 Jan;37(1):16–19. doi: 10.1016/0306-9877(92)90005-w. [DOI] [PubMed] [Google Scholar]
  9. Klein A., Bruser B., Bast M., Rachlis A. Progress of HIV infection and changes in the lipid membrane structure of CD4+ cells. AIDS. 1992 Mar;6(3):332–333. [PubMed] [Google Scholar]
  10. Lafeuillade A., Delbeke E., Chaffanjon P., Aubert L., Dhiver C., Gastaut J. A., Quilichini R. Intérêt du dosage des anticorps anticardiolipine au cours de l'infection par le virus de l'immunodéficience humaine. Presse Med. 1990 Jun 30;19(26):1225–1227. [PubMed] [Google Scholar]
  11. Maclean C., Flegg P. J., Kilpatrick D. C. Anti-cardiolipin antibodies and HIV infection. Clin Exp Immunol. 1990 Aug;81(2):263–266. doi: 10.1111/j.1365-2249.1990.tb03328.x. [DOI] [PMC free article] [PubMed] [Google Scholar]
  12. Malatzky-Goshen E., Shoenfeld Y. AIDS and autoimmunity. Autoimmunity. 1989;3(3):201–212. doi: 10.3109/08916938909099017. [DOI] [PubMed] [Google Scholar]
  13. Maneta-Peyret L., Daverat P., Geffard M., Cassagne C., Orgogozo J. M. Natural seric anti-fatty acid antibodies in multiple sclerosis. Neurosci Lett. 1987 Sep 23;80(2):235–239. doi: 10.1016/0304-3940(87)90660-4. [DOI] [PubMed] [Google Scholar]
  14. Maneta-Peyret L., Picard J. P., Bezian J. H., Cassagne C. Fatty acids rendered immunogenic. Immunol Lett. 1992 Feb 15;31(3):227–232. doi: 10.1016/0165-2478(92)90118-8. [DOI] [PubMed] [Google Scholar]
  15. Morrow W. J., Isenberg D. A., Sobol R. E., Stricker R. B., Kieber-Emmons T. AIDS virus infection and autoimmunity: a perspective of the clinical, immunological, and molecular origins of the autoallergic pathologies associated with HIV disease. Clin Immunol Immunopathol. 1991 Feb;58(2):163–180. doi: 10.1016/0090-1229(91)90134-v. [DOI] [PubMed] [Google Scholar]
  16. Muller S., Richalet P., Laurent-Crawford A., Barakat S., Rivière Y., Porrot F., Chamaret S., Briand J. P., Montagnier L., Hovanessian A. Autoantibodies typical of non-organ-specific autoimmune diseases in HIV-seropositive patients. AIDS. 1992 Sep;6(9):933–942. doi: 10.1097/00002030-199209000-00004. [DOI] [PubMed] [Google Scholar]
  17. Sekigawa I., Groopmen J. E., Allan J. D., Ikeuchi K., Biberfield G., Takatsuki K., Byrn R. A. Characterization of autoantibodies to the CD4 molecule in human immunodeficiency virus infection. Clin Immunol Immunopathol. 1991 Jan;58(1):145–153. doi: 10.1016/0090-1229(91)90156-5. [DOI] [PubMed] [Google Scholar]
  18. Shoji S., Tashiro A., Furuishi K., Takenaka O., Kida Y., Horiuchi S., Funakoshi T., Kubota Y. Antibodies to an NH2-terminal myristoyl glycine moiety can detect NH2-terminal myristoylated proteins in the retrovirus-infected cells. Biochem Biophys Res Commun. 1989 Jul 31;162(2):724–732. doi: 10.1016/0006-291x(89)92370-x. [DOI] [PubMed] [Google Scholar]
  19. Stricker R. B., McHugh T. M., Moody D. J., Morrow W. J., Stites D. P., Shuman M. A., Levy J. A. An AIDS-related cytotoxic autoantibody reacts with a specific antigen on stimulated CD4+ T cells. 1987 Jun 25-Jul 1Nature. 327(6124):710–713. doi: 10.1038/327710a0. [DOI] [PubMed] [Google Scholar]
  20. Via C. S., Morse H. C., 3rd, Shearer G. M. Altered immunoregulation and autoimmune aspects of HIV infection: relevant murine models. Immunol Today. 1990 Jul;11(7):250–255. doi: 10.1016/0167-5699(90)90099-u. [DOI] [PubMed] [Google Scholar]
  21. Zagury J. F., Bernard J., Achour A., Astgen A., Lachgar A., Fall L., Carelli C., Issing W., Mbika J. P., Cantalloube H. HIV-1-induced immune suppression may result from autoimmune disorders including anti-SLWDQ autoantibodies. Biomed Pharmacother. 1993;47(2-3):93–99. doi: 10.1016/0753-3322(93)90297-x. [DOI] [PubMed] [Google Scholar]
  22. Ziegler J. L., Stites D. P. Hypothesis: AIDS is an autoimmune disease directed at the immune system and triggered by a lymphotropic retrovirus. Clin Immunol Immunopathol. 1986 Dec;41(3):305–313. doi: 10.1016/0090-1229(86)90001-2. [DOI] [PubMed] [Google Scholar]

Articles from Clinical and Experimental Immunology are provided here courtesy of British Society for Immunology

RESOURCES